Our findings provide functional and mechanistic evidence to explain how advanced breast cancers commonly metastasize to bone and suggest a potential strategy for the prevention and treatment of breast cancer bone metastatic disease by targeting the EMT/BMP2/RUNX2 pathway and disrupting the interaction between cancer cells and their microenvironment. The gene discussed is BMP2; the disease is breast carcinoma.